ICU MEDICAL INC/DE Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
ICU MEDICAL INC/DE (ICUI) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$3.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$3.21M, a 208.55% decline year-over-year.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $2.96M.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$3.88M, a 300.36% decline year-over-year.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $1.94M.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $8.85M.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$4.93M, a 255.83% decline from fiscal 2023.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $3.16M.
- ICU MEDICAL INC/DE effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$9.48M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.02M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$3.21M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $8.85M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $8.34M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $9.62M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $2.96M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$4.93M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $4.47M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$2.54M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$3.88M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $3.16M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | -$1.10M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $1.85M 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $1.94M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$9.48M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | -$10.48M 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | -$6.35M 10-Q · filed 2023-08-07 | |||
| 2022-03-31 | -$3.22M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$3.25M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | -$2.19M 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $2.85M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |